PERHAPS A GIFT VOUCHER FOR MUM?: MOTHER'S DAY

Close Notification

Your cart does not contain any items

Overcoming Antimicrobial Resistance of the Skin

Stephen K. Tyring Stephen Andrew Moore Angela Yen Moore Omar Lupi

$260.95   $208.95

Paperback

Not in-store but you can order this
How long will it take?

QTY:

English
Springer Nature Switzerland AG
08 May 2022
This book is a thorough, practical review of the challenges facing clinicians treating skin microbes and how to combat these therapeutic dilemmas. It expresses the critical public health concern of antimicrobial resistance and shows how microorganisms are developing the ability to halt the progress of antimicrobials like antibiotics, antivirals, and antifungals. Chapters are grouped together in five sections for ease of use. The first three sections of the book convey foundational information on the mechanisms of antibiotics, antivirals, and antifungals resistance, as well as the  implications of lack of vaccination. The fourth section then turns to the specifics of drug resistance for protozoan and helminth infections focusing primarily on initial and subsequent resistance to treatment.  The book closes with a discussion on the potential solutions of innovative therapy including new delivery mechanisms, broad-spectrum antibiotics, phytocompounds, and biofilms. Chapters feature magnified, microscopic photos for identifying structures as they appear on the skin. Part of the Updates in Clinical Dermatology series, Overcoming Antimicrobial Resistance of the Skin is an important resource relevant during the COVID-19 pandemic, and is written for all medical healthcare professionals.

Edited by:   , , ,
Imprint:   Springer Nature Switzerland AG
Country of Publication:   Switzerland
Edition:   1st ed. 2021
Dimensions:   Height: 254mm,  Width: 178mm, 
Weight:   529g
ISBN:   9783030683238
ISBN 10:   3030683230
Series:   Updates in Clinical Dermatology
Pages:   255
Publication Date:  
Audience:   Professional and scholarly ,  Undergraduate
Format:   Paperback
Publisher's Status:   Active
Section I: Emerging Bacterial Resistance to Antibiotics.- Ch 1: Mechanisms of Bacterial Resistance.- Ch 2: Emerging Bacterial Infections.- Ch 3: Re-Emerging Bacterial Infections of the Skin.- Section II: Emerging Resistance to Antivirals.- Ch 4: Mechanisms of Nonretroviral Resistance.- Ch 5: Mechanisms of Retroviral Resistance.- Ch 6: Emerging Viral Infections.- Ch 7: Re-Emerging Viral Infections - Implications of Lack of Vaccination.- Section III: Emerging Resistance to Antifungals.- Ch 8: Mechanisms of Antifungal Resistance.- Ch 9: Emerging and Re-Emerging Fungal Infections.- Section IV: Emerging Resistance to Drugs for Protozoan and Helminth Infections.- Ch 10: Mechanisms of Anti-Protozoan/Helminth Drug Resistance.- Ch 11: Emerging and Re-Emerging Protozoan/Helminth Infections.- Section V: Innovative Therapies on the Forefront.- Ch 12: Phage Therapy.- Ch 13: The Role of Biofilms and the Microbiome.- Ch 14: New Classes of Broad-Spectrum Antibioticsand New Mechanisms of Delivery.- Ch 15: Phytocompounds.- Ch 16: Summary: Overcoming Antimicrobial Resistance of the Skin. 

Stephen K. Tyring, MD, PhDUniversity of Texas Health Science CenterCenter for Clinical StudiesHouston, TXUSA Stephen Andrew MooreArlington Center for DermatologyArlington Research CenterArlington, TXUSA Angela Yen Moore, MDArlington Center for DermatologyArlington Research CenterArlington, TXUSA Omar Lupi, MD, MSc, PhDUniversidade Federal do Estado do Rio de Janeiro (UNIRIO)Policlinica Geral do Rio de Janeiro (PGRJ)Ibero Latin American College of Dermatology (CILAD) International League of Dermatological Societies (ILDS)Brazil

See Also